Team Lead Reimbursement Director
$220k - $260k+ Short-term incentive program + Long-term incentive program
Expert
Bachelor's
Remote in USA
RemoteTravel up to 25% with some evening and weekend commitments.
Medical, Clinical & Veterinary
About the job
Requirements
- A bachelor's degree is required.
- At least 10 years of experience working in a patient access role for a specialty medication is required.
- Demonstrated expertise with both pharmacy and medical benefits in a specialty disease market is required.
- Strong collaboration with hub partners and cross-functional colleagues is required.
- Familiarity with Office of Inspector General guidance, Health Insurance Portability and Accountability Act guidelines, and Food and Drug Administration protocols is required.
- Ability to travel up to 25% and work some evenings and weekends is required.
- Ability to address critical patient access issues with urgency is required.
- Ability to lead, motivate, and develop high-performing teams is required.
- Ability to prioritize competing demands while balancing individual contributor and leadership responsibilities is required.
- Ability to navigate ambiguous or challenging access scenarios and identify solutions is required.
- Ability to take initiative to move patient cases forward is required.
- Strong interpersonal and communication skills are required.
Responsibilities
- Provide proactive education to healthcare provider offices on insurance requirements and payer policies related to ANI Rare Disease Business Unit brands.
- Manage a limited number of complex reimbursement cases, maintaining direct engagement with healthcare provider offices and patients.
- Partner with hub case managers and in-network specialty pharmacies to support prior authorization submissions and follow-up.
- Facilitate access to patient assistance programs, including copay support and free goods, when applicable.
- Coordinate with Nurse Access Specialists to align patient support activities.
- Partner with Market Access colleagues to stay informed on payer trends, policy changes, and access barriers.
- Collaborate with Sales colleagues, when appropriate and in accordance with compliance guidelines, to support field education and account strategy.
- Serve as a subject matter expert on reimbursement and access, contributing insights to broader team initiatives.
- Balance individual casework with team leadership responsibilities as a player-coach.
- Mentor and coach team members on best practices, compliance, and patient-centric service.
- Monitor team productivity, workload distribution, case quality, and key performance indicators to ensure operational objectives are achieved.
- Support onboarding and ongoing development of team members, fostering a culture of integrity, excellence, and collaboration.
- Conduct regular one-on-one meetings, team meetings, case reviews, and development discussions to support team effectiveness and engagement.
- Model professionalism, ethical conduct, and compliance in all interactions.
About the company
ANI Pharmaceuticals develops, manufactures, and markets prescription medications, including generic and branded products, that are FDA-approved. Its medicines are produced in regulated facilities and go through standard safety and efficacy testing to meet patient needs. The company sells these products to pharmacies, hospitals, and healthcare providers, using a portfolio that spans generic drugs and specialty branded therapies. What sets ANI apart is its combination of a diversified product lineup with growth through strategic acquisitions to expand its offerings and market reach, rather than relying on a single product area. Its goal is to provide high-quality medicines to patients while continuously expanding its portfolio and market presence through acquisitions and manufacturing capabilities.
Company Size
501-1,000
Company Stage
IPO
Headquarters
Baudette, Minnesota
Founded
1996
Get referred to ANI Pharmaceuticals
See people who can refer or advise you
Simplify's Take
What believers are saying
- ANI reported Q2 2026 revenue of $266 million, up 25.9%, beating estimates.
- Management reaffirmed 2026 revenue guidance of $1.08 billion to $1.14 billion.
- Rare-disease sales force expanded 50% to about 180 reps, supporting gout growth.
What critics are saying
- CG Oncology appeal ended badly July 16, 2026; ANI still risks zero recovery.
- Cortrophin depends on single-source contract manufacturing, exposing revenue to supply shocks and FDA disruptions.
- ILUVIEN fell 16.1% in Q2 2026, revealing concentration risk beyond Cortrophin.
What makes ANI Pharmaceuticals unique
- Cortrophin Gel drove 43.5% Q2 2026 growth, powering ANI's rare-disease pivot.
- Henry Gosebruch joined the board August 19, 2026, sharpening dealmaking for rare disease.
- ANI now targets roughly 60% of 2026 revenue from rare disease products.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- 401(k) Retirement Plan
- Unlimited Paid Time Off
- Paid Vacation
- Paid Holidays
- Employee Stock Purchase Plan